Lopid

Lopid (Gemfibrozil) is a medication used to lower lipid levels in the blood. It is commonly prescribed to manage cholesterol and triglyceride levels, supporting cardiovascular health. This oral medication is manufactured by Laboratórios Pfizer Lda.

Lopid is primarily used to reduce levels of triglycerides and cholesterol in the blood. It is often prescribed for individuals with high lipid levels to help manage cardiovascular risk factors. The medication works by increasing the removal of cholesterol from the bloodstream, aiding in the reduction of triglycerides and very low-density lipoproteins (VLDL).

Common effects of Lopid may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may experience muscle pain or weakness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Lopid should be used with caution in individuals with liver or kidney disease. Regular monitoring of liver function may be recommended. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication.

Lopid may interact with other medications, including statins and blood thinners. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while using Lopid, as it may increase the risk of side effects.